US-based company W R Grace is set to expand its pharma portfolio with the acquisition of Albemarle’ Fine Chemistry Services business (FCS) for about $570m.
Albemarle Fine Chemistry Services (FCS), a U.S. domestic supplier of regulatory starting materials (RSMs), intermediates, and high-value active pharmaceutical ingredients (APIs) to the pharmaceutical industry...